3-ketosteroid-delta1-dehydrogenase mutant and application thereof in catalyzing dehydrogenation of steroid compound

Through directional evolution and optimization of the catalytic reaction system, an efficient 3-sterone-Δ1-dehydrogenase mutant was obtained, which solved the problem of low catalytic efficiency caused by substrate insolubleness and achieved a high conversion rate of C1 and 2-position dehydrogenation reaction.

CN120366249AActive Publication Date: 2025-07-25ZHEJIANG UNIV OF TECH
8 Cites 1 Cited by

Patent Information

Application Number
CN202510513848.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2025-04-23
Publication Date
2025-07-25
Estimated Expiration
2045-04-23

AI Technical Summary

Technical Problem

The prior art is difficult to efficiently catalyze the dehydrogenation reaction of (16α)-methylandrost-4,9-diene-3,17-dione at the C1,2 position, and the substrate is difficult to dissolve in water, resulting in low biocatalytic efficiency.

Method used

PrKstD, a mutant 3-sterone-Δ1-dehydrogenase, was obtained through directed evolution, and a recombinant expression vector was constructed and the catalytic reaction system was optimized. The cosolvent Tween-80 was added to improve substrate solubility, and the induction conditions were optimized to improve catalytic efficiency.

Benefits of technology

The conversion rate of (16α)-methylandrost-4,9-diene-3,17-dione was achieved to reach 99.9%, solving the problem of substrate insolubleness, and providing a green, environmentally friendly, safe and efficient biocatalytic path.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The invention discloses a 3-ketosteroid-delta1-dehydrogenase mutant and application of the 3-ketosteroid-delta1-dehydrogenase mutant in catalyzing dehydrogenation of a steroid compound, the mutant with high catalytic activity is obtained through screening, and the solubility of a substrate is increased by adding a cosolvent Tween-80, so that the biological catalytic efficiency is improved. Under the optimal condition, the mutant disclosed by the invention can improve the feeding amount conversion rate of 15g / L of (16 alpha)-methyl androstane-4, 9-diene-3, 17-diketone to 99.9%.
Need to check novelty before this filing date? Find Prior Art